Gara Jalqabaatti › Saree Oljoo › Arizona › Gilbert
Qorannoo klinikaalii Saree Oljoo Gilbert, AZ keessatti
Qorannoo 10 Saree Oljoo f Gilbert fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Banner MD Anderson Cancer Center, Gilbert
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Banner MD Anderson Cancer Center, Gilbert
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
Namoota walitti qabaa jiraSadarkaa 1
- Research Site, Gilbert
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Namoota walitti qabaa jiraSadarkaa 3
- Banner MD Anderson Cancer Center-Oncology ( Site 0004), Gilbert
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
Namoota walitti qabaa jiraSadarkaa 3
- Ironwood Cancer & Research Centers, Gilbert
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Namoota walitti qabaa jiraSadarkaa 3
- Banner MD Anderson Cancer Center ( Site 0066), Gilbert
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Banner Health MD Anderson AZ, Gilbert
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Namoota walitti qabaa jiraSadarkaa 3
- Banner MD Anderson Cancer Center, Gilbert
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Namoota walitti qabaa jiraSadarkaa 3
- Ironwood Cancer & Research Centers, Gilbert
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
Namoota walitti qabaa jiraQorannoo ilaalaa
- Banner - MD Anderson Cancer Center, Gilbert
Qorannoo Saree Oljoo magaalota biroo keessatti
- New York City, NYQorannoo 136
- Houston, TXQorannoo 126
- Boston, MAQorannoo 112
- Nashville, TNQorannoo 81
- Los Angeles, CAQorannoo 73
- Edison, NJQorannoo 68
- St. Louis, MOQorannoo 64
- Queens, NYQorannoo 64
- Durham, NCQorannoo 64
- Chicago, ILQorannoo 59
- Philadelphia, PAQorannoo 56
- Dallas, TXQorannoo 55
Qorannoo biroo Gilbert keessatti
- Kansara Qara'a Non-Small CellQorannoo 13
- Kansarii ColorectalQorannoo 9
- Saree (Gosoota Hunda)Qorannoo 8
- Dhibee QaraQorannoo 8
- Dukkana BladderQorannoo 6
- Cufama OnneeQorannoo 6
- Myeloma Baay’eeQorannoo 6
- Kansa Selii Skwaamoo Mataa fi MormaQorannoo 6
- Dhibee Onneessaa fi DhiigaQorannoo 6
- Kansara MetastatikiiQorannoo 6
- Diffuse Large B-Cell LymphomaQorannoo 5
- Non-Hodgkin LymphomaQorannoo 5
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.